Chief Medical Officer
Cebiotex S.L., Barcelona, Spain, Spain
I hold +36-year experience in pharmaceuticals including local Head of Development of Anti-Infectives at Novartis and at Roche´s spin-off, Basilea Pharmaceutica, both in Basel, Switzerland; Almirall (Head of Development) and Esteve (Medical Director and Board member), Barcelona, Spain.
Nowadays I am consultant for drug development (in some companies acting as Chief Medical Officer or Chairman of the Advisory Board). Among current and past companies: Novartis, Biogen-Idec, MaxiVAX, LASCCO/Combioxin, Santhera, The Medicines Company, Aptarion, AbilityPharma, The European Commission (Eurostars, EUREKA, Horizon 2020), Abionic, Actelion, Pharmamar, Cebiotex, STALICLA, Elan, Pharmamar, Kenta Biotech, Debiopharm, Polyneuron, and others).
Within drug R&D, I developed, registered, launched and marketed drugs in oncology, infectious diseases, and neurology, among others. I am/have been leader/member of several Boards and Steering committees and worldwide Product-, Project, Marketing- and Publication teams, and/or departments and Head of a whole Medical Group including Medical Marketing, Clinical Research and Pharmacovigilance, and had cross-functional activities or responsibilities with key departments: Marketing, Business Development, Finances, Regulatory Affairs, and Research. I have selected, and managed worldwide key opinion leaders, scientific advisors and experts from selected centers of research. My activities and projects have been carried out in all five continents, from Phase I to IV, having met or submitted documents to a broad panel of Regulatory Agencies (e.g. FDA, EMA, MHRA, PEI, BfArM, Swiss-Medic, ANSM, MPA, AEMPS). Some of my projects ended up with a local, multinational, and/or worldwide registration.
